CLENE INC (CLNN) Fundamental Analysis & Valuation

NASDAQ:CLNN • US1856342019

Current stock price

4.71 USD
-0.68 (-12.62%)
Last:

This CLNN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. CLNN Profitability Analysis

1.1 Basic Checks

  • CLNN had negative earnings in the past year.
  • CLNN had a negative operating cash flow in the past year.
  • CLNN had negative earnings in each of the past 5 years.
  • CLNN had a negative operating cash flow in each of the past 5 years.
CLNN Yearly Net Income VS EBIT VS OCF VS FCFCLNN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M -40M

1.2 Ratios

  • CLNN has a Return On Assets of -136.69%. This is amonst the worse of the industry: CLNN underperforms 82.47% of its industry peers.
Industry RankSector Rank
ROA -136.69%
ROE N/A
ROIC N/A
ROA(3y)-127.69%
ROA(5y)-93.15%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CLNN Yearly ROA, ROE, ROICCLNN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K

1.3 Margins

  • The Gross Margin of CLNN (82.24%) is better than 85.55% of its industry peers.
  • CLNN's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for CLNN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 82.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.41%
GM growth 5Y3.32%
CLNN Yearly Profit, Operating, Gross MarginsCLNN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K -6K -8K -10K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. CLNN Health Analysis

2.1 Basic Checks

  • CLNN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, CLNN has more shares outstanding
  • CLNN has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CLNN has a worse debt to assets ratio.
CLNN Yearly Shares OutstandingCLNN Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CLNN Yearly Total Debt VS Total AssetsCLNN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of -21.10, we must say that CLNN is in the distress zone and has some risk of bankruptcy.
  • CLNN's Altman-Z score of -21.10 is on the low side compared to the rest of the industry. CLNN is outperformed by 84.59% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -21.1
ROIC/WACCN/A
WACC10.44%
CLNN Yearly LT Debt VS Equity VS FCFCLNN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M

2.3 Liquidity

  • CLNN has a Current Ratio of 1.53. This is a normal value and indicates that CLNN is financially healthy and should not expect problems in meeting its short term obligations.
  • CLNN's Current ratio of 1.53 is on the low side compared to the rest of the industry. CLNN is outperformed by 82.27% of its industry peers.
  • CLNN has a Quick Ratio of 1.52. This is a normal value and indicates that CLNN is financially healthy and should not expect problems in meeting its short term obligations.
  • CLNN has a Quick ratio of 1.52. This is amonst the worse of the industry: CLNN underperforms 80.35% of its industry peers.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.52
CLNN Yearly Current Assets VS Current LiabilitesCLNN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CLNN Growth Analysis

3.1 Past

  • CLNN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 56.23%, which is quite impressive.
  • The Revenue for CLNN has decreased by -41.52% in the past year. This is quite bad
  • CLNN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.97% yearly.
EPS 1Y (TTM)56.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.69%
Revenue 1Y (TTM)-41.52%
Revenue growth 3Y-24.78%
Revenue growth 5Y-0.97%
Sales Q2Q%-15.38%

3.2 Future

  • CLNN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 44.56% yearly.
  • Based on estimates for the next years, CLNN will show a very strong growth in Revenue. The Revenue will grow by 430.93% on average per year.
EPS Next Y18.4%
EPS Next 2Y28.64%
EPS Next 3Y30.06%
EPS Next 5Y44.56%
Revenue Next Year43.04%
Revenue Next 2Y1615.13%
Revenue Next 3Y925.29%
Revenue Next 5Y430.93%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CLNN Yearly Revenue VS EstimatesCLNN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
CLNN Yearly EPS VS EstimatesCLNN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 10 -10 20

More info and screens

Find the best growth stocksShow best growing peers

1

4. CLNN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CLNN. In the last year negative earnings were reported.
  • Also next year CLNN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLNN Price Earnings VS Forward Price EarningsCLNN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CLNN Per share dataCLNN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2 -2.5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CLNN's earnings are expected to grow with 30.06% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.64%
EPS Next 3Y30.06%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CLNN Dividend Analysis

5.1 Amount

  • CLNN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CLNN Fundamentals: All Metrics, Ratios and Statistics

CLENE INC

NASDAQ:CLNN (3/27/2026, 4:30:01 PM)

4.71

-0.68 (-12.62%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-12
Earnings (Next)05-05
Inst Owners17.89%
Inst Owner Change47.92%
Ins Owners19.2%
Ins Owner Change0.42%
Market Cap51.10M
Revenue(TTM)200.00K
Net Income(TTM)-30.50M
Analysts81.67
Price Target32.64 (592.99%)
Short Float %10.95%
Short Ratio9.24
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-52.62%
Min EPS beat(2)-61.56%
Max EPS beat(2)-43.68%
EPS beat(4)1
Avg EPS beat(4)-26.62%
Min EPS beat(4)-91.95%
Max EPS beat(4)90.71%
EPS beat(8)4
Avg EPS beat(8)-7.25%
EPS beat(12)6
Avg EPS beat(12)-1.71%
EPS beat(16)9
Avg EPS beat(16)12.69%
Revenue beat(2)0
Avg Revenue beat(2)-61.61%
Min Revenue beat(2)-73.33%
Max Revenue beat(2)-49.89%
Revenue beat(4)1
Avg Revenue beat(4)-28.67%
Min Revenue beat(4)-73.33%
Max Revenue beat(4)39.93%
Revenue beat(8)2
Avg Revenue beat(8)-19.69%
Revenue beat(12)4
Avg Revenue beat(12)1.91%
Revenue beat(16)6
Avg Revenue beat(16)9%
PT rev (1m)0.45%
PT rev (3m)0.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.27%
EPS NY rev (1m)3.56%
EPS NY rev (3m)3.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-26.02%
Revenue NY rev (1m)-21.43%
Revenue NY rev (3m)-21.43%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 238.8
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.6
EYN/A
EPS(NY)-2.12
Fwd EYN/A
FCF(TTM)-1.72
FCFYN/A
OCF(TTM)-1.72
OCFYN/A
SpS0.02
BVpS-1.14
TBVpS-1.14
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -136.69%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 82.24%
FCFM N/A
ROA(3y)-127.69%
ROA(5y)-93.15%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.41%
GM growth 5Y3.32%
F-Score2
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.78%
Cap/Sales 5.61%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.53
Quick Ratio 1.52
Altman-Z -21.1
F-Score2
WACC10.44%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.69%
EPS Next Y18.4%
EPS Next 2Y28.64%
EPS Next 3Y30.06%
EPS Next 5Y44.56%
Revenue 1Y (TTM)-41.52%
Revenue growth 3Y-24.78%
Revenue growth 5Y-0.97%
Sales Q2Q%-15.38%
Revenue Next Year43.04%
Revenue Next 2Y1615.13%
Revenue Next 3Y925.29%
Revenue Next 5Y430.93%
EBIT growth 1Y29.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-50.38%
EBIT Next 3Y22.73%
EBIT Next 5Y72.14%
FCF growth 1Y21.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.24%
OCF growth 3YN/A
OCF growth 5YN/A

CLENE INC / CLNN Fundamental Analysis FAQ

What is the fundamental rating for CLNN stock?

ChartMill assigns a fundamental rating of 2 / 10 to CLNN.


Can you provide the valuation status for CLENE INC?

ChartMill assigns a valuation rating of 1 / 10 to CLENE INC (CLNN). This can be considered as Overvalued.


What is the profitability of CLNN stock?

CLENE INC (CLNN) has a profitability rating of 1 / 10.


Can you provide the financial health for CLNN stock?

The financial health rating of CLENE INC (CLNN) is 1 / 10.